Oramed Pharmaceuticals (ORMP) Q3 2023 Earnings

8NovExpected
Jan 23
Q1 2023
Q2 2023
Q3 2023
-0.26
-0.18
-0.11
-0.03

Details

Expected EPS
-0.1
Actual EPS
-0.03
Surprise EPS
0.07
Surprise Percent
+70%

Description

Oramed Pharmaceuticals (ORMP) has reported earnings of -0.03 per share for Q3 2023.

0 Comments

Share your thoughts